ArticlePloS one2025

Cost-utility analysis of botulinum toxin type A versus oral drug treatment in patients with severe blepharospasm in Thailand.

Parima Hirunwiwatkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.